StockData
PPBTNasdaqPharmaceutical PreparationsFiscal year ends December 31

PURPLE BIOTECH LTD.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 19, 2026
$1.08−0.06 (-5.26%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
40.0
Dividend yield
–

PURPLE BIOTECH LTD. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Purple Biotech does not break out revenue by segment, region or product in the tagged data of its filings for this period type.